Private Placement

With final funding secured, Microporous is set to begin construction on a massive Virginia plant, a key step in strengthening America's EV supply chain.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.

With its upgrade to the OTCQX market, Koryx Copper gains crucial access to U.S. investors, aiming to fund its massive Haib copper project in Namibia.

Taiwanese firm Smart Power System unveils an AI-driven strategy to build disaster-proof microgrids and export its advanced energy technology worldwide.

The Canadian miner's new OTCQB listing aims to attract American capital, fueling exploration of its promising gold and copper assets in British Columbia.

The company marks a pivotal transition from developer to producer, commencing leaching at its flagship Argentine project and setting sights on major growth.

With a $1.8M grant, AltaLink is using real-time weather data to unlock hidden capacity in power lines, saving money and boosting grid reliability.

Royal Columbian Hospital's new integrated imaging centre, a gift from the Gin Foundation, promises to slash diagnostic times and save lives.

Following a key investment, InterProse adds fintech leaders Ron Totaro and Ray Peloso to its board, signaling a major push in the debt recovery market.

A new study shows RIVANNA's Accuro XV allows staff with minimal training to get diagnostic images, promising to speed up care and reduce ER wait times.

Investment firm Malar Group backs wellness startup Attaboy Labs, betting on clinical science over marketing hype in the booming supplement industry.

With patient enrollment accelerating for its novel lung fibrosis drug, LTI-03, Rein Therapeutics signals progress in a field desperate for new options.

Seattle startup CounterX Therapeutics to present its novel overdose prevention drug at a top investor event, signaling new hope in the fentanyl crisis.

A new advisory firm is tackling the opaque world of aesthetic device sales, promising to save providers up to $80,000 on high-ticket equipment.

Scholar Hotels is launching a $5,000 minimum investment platform for its State College properties, tapping into alumni loyalty and a new era of retail investing.

Scottish biotech EnteroBiotix secures major funding to advance its gut therapy for IBS-C, offering new hope for a disease-modifying treatment.

With strategic investments and a new Cannes workshop, Yoshihiro Shimamura is building an integrated media empire to export Japanese culture worldwide.

With financials improving but competition rising, medical device maker Pulmonx faces a critical audience at the BofA healthcare conference in May.

The new AI platform iQ aims to translate complex supply chain threats into quantifiable financial exposure, giving CFOs a new tool for strategic decisions.

A new ultra-short-acting drug for cardiac emergencies is now in US hospitals, offering doctors faster control and broader use across all age groups.